Chi Sheng Pharma & Biotech Co., Ltd.(TW:4111)
NT$28.50+0.05 (+1.06%)
TW:4111
Chi Sheng Pharma & Biotech Co., Ltd. Revenue
NT$28.50
At close:+0.05 (+1.06%)
Chi Sheng Pharma & Biotech Co., Ltd. (4111) Revenue
Chi Sheng Pharma & Biotech Co., Ltd. Revenue
Chi Sheng Pharma & Biotech Co., Ltd. had a revenue of 375.11M in the quarter ending Jun 30, 2026, with 5.14%. This bring the company's revenue in the last twelve months to 1.42B, Increased 0.52%. In the fiscal year ending Dec 31, 2025, Chi Sheng Pharma & Biotech Co., Ltd. had annual revenue of 1.38B with 18.11% growth.
- Revenue (ttm)
- 1.42B
- Revenue Growth
- 5.33%
- P/S Ratio
- 1.24
- Revenue/Employee
- TWD 17,206,000
- Employees
- 80
- Market Cap
- TWD 1.71B
Revenue Chart
Chi Sheng Pharma & Biotech Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.38B | 211.04M | 18.11% |
| Dec 31, 2024 | 1.17B | 104.57M | 9.86% |
| Dec 31, 2023 | 1.06B | -82.21M | -7.19% |
| Dec 31, 2022 | 1.14B | 120.78M | 11.81% |
| Dec 31, 2021 | 1.02B | 42.94M | 4.38% |
| Dec 31, 2020 | 979.36M | -43.60M | -4.26% |
| Dec 31, 2019 | 1.02B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.